Latest papers

Hirsutane-type sesquiterpenes with uncommon modifications from three basidiomycetes.

Synthesis and study of the use of heterocyclic thiosemicarbazones as signaling scaffolding for the recognition of anions.

Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?

Status of bi- and multi-nuclear platinum anticancer drug development.

Formation of beyerene, kaurene, trachylobane, and atiserene diterpenes by rearrangements that avoid secondary carbocations.

[Microbiological transformation of paeoniflorin and albiflorin].

Stereoselective synthesis of configurationally stable functionalized ethano-bridged Tröger bases.

DFT and MP2 study on the electrophilic addition reaction of bromine to exo-tricyclo[3.2.1.0(2.4)]oct-6-ene.

Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation.

Simultaneous determination of four marker components in Yukmijihwang Tang by high performance liquid chromatography/diode array detector.

Biological catalysis regulated by cucurbit[7]uril molecular containers.

Binding studies on CB[6] with a series of 1-alkyl-3-methylimidazolium ionic liquids in an aqueous system.

[Extra- and paravasation of cytotoxic drugs. Pathomechanisms and current preventive measures]

Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.

Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects.

Targeted therapies: tailored treatment for ovarian cancer: are we there yet?

Can a cure be achieved with taxane-based chemotherapy plus surgery in patients with primary mediastinal non-seminomatous germ cell tumors and progression or relapse despite first-line chemotherapy?

Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius.

Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.

[Substantiation of possibility of use GABA-receptor's chloride channel blockers for modelling of the temporal epilepsy].